Ebola Vaccine Trials Underway For Congo Strain
Moderna is developing an Ebola vaccine to combat the ongoing epidemic in Congo. The vaccine aims to provide a new tool in controlling the spread of the virus. Moderna has received $50 million to develop an mRNA Ebola vaccine against the Bundibugyo virus.
Topics
Developing
- 907d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 907d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 907d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 907d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
Mastodon
“Moderna développe un vaccin contre Ebola pour lutter contre l’épidémie en Congo – Business AM”
Mastodon
“Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo”
Mastodon
“A Moderna anuncia parceria para desenvolver vacina contra cepa Bundibugyo do Ebola com a Coalizão para Inovações em Preparação para Epidemias, Cepi, fundação que financia projetos independentes de pes...”
Mastodon
“There is an effective vaccine for Ebola — but not for the variety spreading rapidly in the Democratic Republic of Congo.”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade